A
Andrew Simon Cook
Researcher at Pfizer
Publications - 35
Citations - 1708
Andrew Simon Cook is an academic researcher from Pfizer. The author has contributed to research in topics: Female Sexual Arousal Disorder & Allosteric regulation. The author has an hindex of 17, co-authored 35 publications receiving 1561 citations. Previous affiliations of Andrew Simon Cook include Imperial College London.
Papers
More filters
Journal ArticleDOI
Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation
Jason Wray,T. Kalkan,Sandra Gómez-López,Sandra Gómez-López,Dominik Eckardt,Andrew Simon Cook,Rolf Kemler,Austin Smith +7 more
TL;DR: It is demonstrated that β-catenin is not necessary for embryonic stem cell identity or expansion, but its absence eliminates the self-renewal response to Gsk3 inhibition, which stabilizes the embryonic stem Cell state primarily by reducing repressive influence on the core pluripotency network.
Journal ArticleDOI
Identification of a Chemical Probe for Bromo and Extra C‑Terminal Bromodomain Inhibition through Optimization of a Fragment- Derived Hit
Paul V. Fish,Panagis Filippakopoulos,Gerwyn Bish,Paul Brennan,Mark E. Bunnage,Andrew Simon Cook,Oleg Federov,Brian S. Gerstenberger,Hannah M. Jones,Stefan Knapp,Brian D. Marsden,Karl Nocka,Dafydd R. Owen,Martin Philpott,Sarah Picaud,Michael J. Primiano,Michael J. Ralph,Nunzio Sciammetta,John David Trzupek +18 more
TL;DR: The discovery and structure–activity relationship (SAR) of a novel, small-molecule chemical probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques has yielded a potent, selective compound with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.
Journal ArticleDOI
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
Rishi G. Vaswani,Victor S. Gehling,Les A. Dakin,Andrew Simon Cook,Christopher G. Nasveschuk,Martin Duplessis,Priyadarshini Iyer,Srividya Balasubramanian,Feng Zhao,Andrew C. Good,Robert K. Campbell,Christina O. Lee,Nico Cantone,Richard T. Cummings,Emmanuel Normant,Steven F. Bellon,Brian K. Albrecht,Jean-Christophe Harmange,Patrick Trojer,James E. Audia,Ying Zhang,Neil Justin,Shuyang Chen,Jon R. Wilson,Steven J. Gamblin +24 more
TL;DR: The optimization of the indole-based EZH2 inhibitor series led to the identification of CPI-1205, a highly potent and selective inhibitor of EZh2 that demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID and is currently in Phase I clinical trials.
Journal ArticleDOI
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.
Timothy P. C. Rooney,Panagis Filippakopoulos,Oleg Fedorov,Sarah Picaud,Wilian A. Cortopassi,Duncan Hay,Sarah Martin,Anthony Tumber,Catherine M. Rogers,Martin Philpott,Minghua Wang,Amber L. Thompson,Tom D. Heightman,Tom D. Heightman,David C. Pryde,Andrew Simon Cook,Robert S. Paton,Susanne Müller,Stefan Knapp,Paul Brennan,Stuart J. Conway +20 more
TL;DR: Structural and computational studies reveal that an internal hydrogen bond stabilizes the protein-bound conformation of the dihydroquinoxalinone series and inhibits binding of CREBBP to chromatin in U2OS cells.
Patent
Modulators of methyl modifying enzymes, compositions and uses thereof
Brian K. Albrecht,James Edmund Audia,Andrew Simon Cook,Les A. Dakin,Martin Duplessis,Victor S. Gehling,Jean-Christophe Harmange,Christopher G. Nasveschuk,Rishi G. Vaswani +8 more
TL;DR: Agents for modulating methyl modifying enzymes, compositions and uses of such enzymes are described in this article, along with their properties and their applications in the field of bioinformatics.